BIOMATRIX ALPHA ™
Drug-eluting coronary stent · class IV · Until 16/09/2029
- Registration no.
- 80433810005
- Process no.
- 25351765253201819
- Status
- Until 16/09/2029
- Device type
- Drug-eluting coronary stent (STENT FARMACOLÓGICO PARA ARTÉRIAS CORONÁRIAS)
- Risk class
- IV
- Registration holder
- SAUDE IMPORT - COMÉRCIO DE PRODUTOS MÉDICOS HOSPITALARES LTDA CNPJ 07.956.849/0001-82 · 60 registrations
- Manufacturer
- Published
- 16/09/2019
- Valid until
- 16/09/2029
- Last updated by ANVISA
- 2026-10-12
- Official record
- View on ANVISA ↗